Pharmaceutical policy in Trinidad and Tobago

Sameer Dhingra, Sandeep Maharaj, Rian Marie Extavour, Zaheer Ud Din Babar

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This chapter describes the pharmaceutical policy landscape in Trinidad and Tobago. The Republic of Trinidad and Tobago is a twin-island democratic nation located off the north coast of Venezuela in the Caribbean. The country is experiencing an epidemiological transition with a decline in the incidence of communicable diseases, and increases in chronic, noncommunicable diseases. Therefore, it is critical that pharmaceutical polices are reflective of our new health realities. This chapter sets the base for examining the country’s polices by exploring its health and regulatory system. It takes an in-depth look at the processes, which are in place and identifies gaps and best practices, which takes place in Trinidad and Tobago. The authors delve into identifying the county’s procurement and distribution system of pharmaceuticals within the public sectors and how are these processes financed. The role of the pharmacist and prescribing practices of doctors are also examined with a view to gain an understanding of the entire system. Trinidad and Tobago has significant policies, processes, and agencies in place to encourage best pharmaceutical practices. However, there continues to be gaps with implementation of some policies and processes, which hinders compliance. This chapter finally details these challenges.

Original languageEnglish
Title of host publicationPharmaceutical Policy in Countries with Developing Healthcare Systems
PublisherSpringer International Publishing AG
Pages349-363
Number of pages15
ISBN (Electronic)9783319516738
ISBN (Print)9783319516721
DOIs
Publication statusPublished - 1 Jan 2017

Fingerprint

Trinidad and Tobago
Drug and Narcotic Control
Police
Practice Guidelines
Pharmaceutical Preparations
Venezuela
Public Sector
Health
Pharmacists
Islands
Compliance
Communicable Diseases
Chronic Disease
Incidence

Cite this

Dhingra, S., Maharaj, S., Extavour, R. M., & Babar, Z. U. D. (2017). Pharmaceutical policy in Trinidad and Tobago. In Pharmaceutical Policy in Countries with Developing Healthcare Systems (pp. 349-363). Springer International Publishing AG. https://doi.org/10.1007/978-3-319-51673-8_17
Dhingra, Sameer ; Maharaj, Sandeep ; Extavour, Rian Marie ; Babar, Zaheer Ud Din. / Pharmaceutical policy in Trinidad and Tobago. Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG, 2017. pp. 349-363
@inbook{f0b9e9e6e75c434da262b3e08aad021d,
title = "Pharmaceutical policy in Trinidad and Tobago",
abstract = "This chapter describes the pharmaceutical policy landscape in Trinidad and Tobago. The Republic of Trinidad and Tobago is a twin-island democratic nation located off the north coast of Venezuela in the Caribbean. The country is experiencing an epidemiological transition with a decline in the incidence of communicable diseases, and increases in chronic, noncommunicable diseases. Therefore, it is critical that pharmaceutical polices are reflective of our new health realities. This chapter sets the base for examining the country’s polices by exploring its health and regulatory system. It takes an in-depth look at the processes, which are in place and identifies gaps and best practices, which takes place in Trinidad and Tobago. The authors delve into identifying the county’s procurement and distribution system of pharmaceuticals within the public sectors and how are these processes financed. The role of the pharmacist and prescribing practices of doctors are also examined with a view to gain an understanding of the entire system. Trinidad and Tobago has significant policies, processes, and agencies in place to encourage best pharmaceutical practices. However, there continues to be gaps with implementation of some policies and processes, which hinders compliance. This chapter finally details these challenges.",
author = "Sameer Dhingra and Sandeep Maharaj and Extavour, {Rian Marie} and Babar, {Zaheer Ud Din}",
year = "2017",
month = "1",
day = "1",
doi = "10.1007/978-3-319-51673-8_17",
language = "English",
isbn = "9783319516721",
pages = "349--363",
booktitle = "Pharmaceutical Policy in Countries with Developing Healthcare Systems",
publisher = "Springer International Publishing AG",
address = "Switzerland",

}

Dhingra, S, Maharaj, S, Extavour, RM & Babar, ZUD 2017, Pharmaceutical policy in Trinidad and Tobago. in Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG, pp. 349-363. https://doi.org/10.1007/978-3-319-51673-8_17

Pharmaceutical policy in Trinidad and Tobago. / Dhingra, Sameer; Maharaj, Sandeep; Extavour, Rian Marie; Babar, Zaheer Ud Din.

Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG, 2017. p. 349-363.

Research output: Chapter in Book/Report/Conference proceedingChapter

TY - CHAP

T1 - Pharmaceutical policy in Trinidad and Tobago

AU - Dhingra, Sameer

AU - Maharaj, Sandeep

AU - Extavour, Rian Marie

AU - Babar, Zaheer Ud Din

PY - 2017/1/1

Y1 - 2017/1/1

N2 - This chapter describes the pharmaceutical policy landscape in Trinidad and Tobago. The Republic of Trinidad and Tobago is a twin-island democratic nation located off the north coast of Venezuela in the Caribbean. The country is experiencing an epidemiological transition with a decline in the incidence of communicable diseases, and increases in chronic, noncommunicable diseases. Therefore, it is critical that pharmaceutical polices are reflective of our new health realities. This chapter sets the base for examining the country’s polices by exploring its health and regulatory system. It takes an in-depth look at the processes, which are in place and identifies gaps and best practices, which takes place in Trinidad and Tobago. The authors delve into identifying the county’s procurement and distribution system of pharmaceuticals within the public sectors and how are these processes financed. The role of the pharmacist and prescribing practices of doctors are also examined with a view to gain an understanding of the entire system. Trinidad and Tobago has significant policies, processes, and agencies in place to encourage best pharmaceutical practices. However, there continues to be gaps with implementation of some policies and processes, which hinders compliance. This chapter finally details these challenges.

AB - This chapter describes the pharmaceutical policy landscape in Trinidad and Tobago. The Republic of Trinidad and Tobago is a twin-island democratic nation located off the north coast of Venezuela in the Caribbean. The country is experiencing an epidemiological transition with a decline in the incidence of communicable diseases, and increases in chronic, noncommunicable diseases. Therefore, it is critical that pharmaceutical polices are reflective of our new health realities. This chapter sets the base for examining the country’s polices by exploring its health and regulatory system. It takes an in-depth look at the processes, which are in place and identifies gaps and best practices, which takes place in Trinidad and Tobago. The authors delve into identifying the county’s procurement and distribution system of pharmaceuticals within the public sectors and how are these processes financed. The role of the pharmacist and prescribing practices of doctors are also examined with a view to gain an understanding of the entire system. Trinidad and Tobago has significant policies, processes, and agencies in place to encourage best pharmaceutical practices. However, there continues to be gaps with implementation of some policies and processes, which hinders compliance. This chapter finally details these challenges.

UR - http://www.scopus.com/inward/record.url?scp=85034396392&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-51673-8_17

DO - 10.1007/978-3-319-51673-8_17

M3 - Chapter

SN - 9783319516721

SP - 349

EP - 363

BT - Pharmaceutical Policy in Countries with Developing Healthcare Systems

PB - Springer International Publishing AG

ER -

Dhingra S, Maharaj S, Extavour RM, Babar ZUD. Pharmaceutical policy in Trinidad and Tobago. In Pharmaceutical Policy in Countries with Developing Healthcare Systems. Springer International Publishing AG. 2017. p. 349-363 https://doi.org/10.1007/978-3-319-51673-8_17